Superpower Daily

Superpower Daily

Your reading space

Sign in
Garry Tan Says Regulators Shouldn’t Curb Alleged Model Distilla...GSA Sets October Shift to Zero-Fee, Usage-Based OpenAI PricingPentagon Negotiates $5B Fluidstack Loan for AI Power and Coolin...TSMC Reports Record August Revenue as AI-Chip Demand Holds Stro...Anthropic Says It Removed Claude Accounts Tied to Nine Influenc...Enflame Shares Rise 206% in Shanghai Debut, Backing Its Next AI...Garry Tan Says Regulators Shouldn’t Curb Alleged Model Distilla...GSA Sets October Shift to Zero-Fee, Usage-Based OpenAI PricingPentagon Negotiates $5B Fluidstack Loan for AI Power and Coolin...TSMC Reports Record August Revenue as AI-Chip Demand Holds Stro...Anthropic Says It Removed Claude Accounts Tied to Nine Influenc...Enflame Shares Rise 206% in Shanghai Debut, Backing Its Next AI...
Swipe

UK Minister Warns Palantir Mistrust May Curb NHS Data Sharing

The government’s decision on a £330 million health-data contract now sits alongside a rise in research opt-outs and unresolved questions over the platform’s claimed results.

By 2 min read
UK Minister Warns Palantir Mistrust May Curb NHS Data Sharing
UK Minister Warns Palantir Mistrust May Curb NHS Data Sharing

Listen to this story

The audio brief

About 1:29
0:001:29
Read transcript
An additional 60,000 people opted out of allowing their NHS information to be used for research and planning between mid-May and mid-July. The increase is modest, according to Health Innovation Minister James Frith, but he says mistrust of Palantir could make patients less willing to share data in the future. These opt-outs do not affect the use of records for someone’s direct care. They apply specifically to research and planning, which makes the issue bigger than a single technology contract: confidence in the data system itself is now part of the debate. The government is considering whether to use a break clause in Palantir’s £330 million, seven-year agreement to run the NHS federated data platform. Doctors and patient groups want the contract ended, while NHS trusts can choose alternatives, meaning local adoption may vary whatever ministers decide nationally. Palantir says trusts using its technology recorded 110,000 additional operations, 15% fewer discharge delays for long-stay patients, and a 6.8% improvement in notifying patients of cancer results within 28 days. NHS England has reported similar figures, but says they do not establish cause and effect. The UK statistics watchdog is investigating the performance data. The immediate question is therefore twofold: whether Palantir keeps the national contract, and whether the controversy reduces participation in the NHS data-sharing system it depends on.

Story brief

3 key points

The UK’s NHS data-platform dispute now includes a participation risk: 60,000 additional people opted out of research and planning data use between mid-May and mid-July. Health Innovation Minister James Frith said mistrust of Palantir could weaken future data sharing, while ministers consider terminating the company’s £330 million, seven-year NHS federated data platform contract. Palantir’s reported operational gains...

  1. 01

    The 60,000 opt-outs do not block use of NHS records for an individual’s direct care.

  2. 02

    Ministers are considering a break clause in Palantir’s £330 million, seven-year agreement.

  3. 03

    NHS trusts can choose alternatives, so local adoption may diverge from the national contract decision.

An additional 60,000 people withdrew consent for their NHS information to be used in research and planning from mid-May to mid-July, as Health Innovation Minister James Frith warned that mistrust of Palantir could make patients less willing to share data.

The opt-outs use a national mechanism that stops records being used for research and planning, while leaving their use for an individual’s direct care intact. Frith described the increase as modest, but said it would be monitored. His warning puts confidence in the data system alongside the government’s pending contract decision.

A contract decision under public scrutiny

The UK government is deciding whether to terminate Palantir’s £330 million, seven-year agreement to operate the NHS federated data platform, a system intended to improve efficiency and patient outcomes. Doctors and patients’ groups want ministers to use a break clause in that agreement.

Trusts may choose another route

Frith also said NHS trusts are not required to use the platform and may prefer an alternative. That leaves local adoption separate from the national contract: the agreement could remain in place even as individual trusts choose other systems.

Performance claims do not settle the dispute

Palantir says trusts using its technology recorded 110,000 additional operations, a 15% reduction in discharge delays for long-stay patients, and a 6.8% improvement in 28-day cancer-result notification rates. Those are company-supplied figures offered as evidence that the platform is improving care.

NHS England has reported similar figures but said it could not draw conclusions about cause and effect. The UK government’s statistics watchdog is investigating the data, leaving the claimed benefits under scrutiny as ministers weigh the contract’s future.

Trust is now part of the platform debate

The choice is no longer only whether Palantir’s platform delivers operational gains. Frith’s concern is that mistrust of the supplier could reduce participation in the research and planning data on which the NHS relies, even if the platform stays available.

Sources

  1. theguardian.com‘Mistrust’ of Palantir may affect NHS research, says health minister

Loading discussion...

Related coverage

Continue reading